Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Int J Med Microbiol. 2015 May 4;305(0):480–490. doi: 10.1016/j.ijmm.2015.04.005

Table 3. Number and percentage of antimicrobial resistant Shigella strains.

Microorganism serotype* N Amp
Sxt
Tet
Chl
Azm1
n % n % n % n % n %
S. flexneri 55 40 73 47 85 42 76 39 71 1 2
2a 28 25 89 26a 93 27a 96 24c 86 1 4
4a 6 0 -- 6 100 0 -- 0 -- 0 --
Other 21 15 71 15 71 15b 71 15a 71 0 --

S. boydii 12 3 25 9 75 6 a 50 2 17 0 --

S. sonnei 12 12 100 12 100 12 100 12 100 4 33
I** 7 7 100 7 100 7 100 7 100 1 14
II 5 5 100 5 100 5 100 5 100 3 60

S. dysenteriae 4 1 25 3 75 1 25 1 25 1 25

Total 83 56 67 71 86 61 74 54 65 6 7
1

: Isolates which posses a azithromycin halo less than 15 mm, In all cases the MIC ranges between 4 and 8 μg/ml.

*

Only those with at minimum of 5 isolates;

**

In the case of S. sonnei, refers to phase

a

: 1 intermediate isolate,

b

: 2 intermediate isolates,

c

: 6 intermediate isolates

Amp: Ampicillin, Sxt: trimethoprim-sulfamethoxazole; Tet: Tetracycline; Chl: Chloramphenicol; Azm: Azithromycin

No resistance to nalidixic acid, ciprofloxacin or ceftriaxone was found, and only 1 intermediate isolate to nitrofurantoin was detected.